Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Discover tailored wealth management advice for women to maximize their assets. Enhance your financial strategy now.
18,329 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
As kimball (ke) 2026 earnings unfold, investors care most about revenue growth, margin stability, and cash flow. This...
Publicly traded lenders, brokerages, and builders posted a mixed bag of Q1 2026 results as higher borrowing costs and...
A fund exited its Centerra Gold stake after a 150% rally, triggering talks of profit-taking and risk management. This...
Solesence kicked off 2026 with a solid Q1 showing across core segments. This deep dive breaks down the numbers, what ...
A tech fund placed a sizable bet on a fresh AI chip IPO, wagering roughly $5.8 million. The stock climbed almost 200%...
AI stocks have dominated headlines, but long-term winners often come from durable franchises. This article explains w...
A large fund sold about $17 million in ZoomInfo shares while the company posted slim revenue growth. This article bre...
A single speech by Jensen Huang can tilt markets. This article explains what these words from Jensen might mean for N...
As Movado prepares for its Q1 2027 earnings, investors want clarity on demand, margins, and licensing deals. This gui...
A recent SEC filing shows Pale Fire Capital expanding its Ziff Davis position. This move offers clues about hedge fun...
Two bold players are trying to reinvent how nuclear power sits in the grid. This guide breaks down Nano Nuclear Energ...